Tabay, Krizza Jean E.

HRN: 21-98-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFUROXIME 750MG (VIAL)
05/29/2023
06/05/2023
IV
750mg
Q8hrs
For Thyroid Lobectomy And Isthmustectomy Under GA
06/05/2023
CEFUROXIME 500MG (TAB)
06/05/2023
06/06/2023
PO
500mg
Bid
S/p Thyroid Lobectomy Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: